Insiders Trades

★ Sign in to follow

FO

Frederic Ors

Immunovaccine Inc.

Cumul. flow

Total declarations

19

Company

1

▲ Purchases (14 ops.)

€143k

▼ Sales (0 ops.)

—

Latest filing published 13 Feb 2018 for Immunovaccine Inc., €19k.

Filing timeline

BuySale

Frederic Ors

Insider track record

Disclosed buys

14

Disclosed sells

0

Signal history

Frederic Ors: trading record in brief

Frederic Ors appears in our data through filings on Immunovaccine Inc. shares, published by SEDI. In total, 19 filings cover trades dated from 27 April 2015 to 13 February 2018.

Every open-market trade on record is a purchase: 14 purchases worth €143k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2018, the count stands at 2 purchases and no sales.

The median purchase comes to €8,304. Across 14 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 13 February 2018: an open-market purchase of €19k, in Immunovaccine Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Frederic Ors

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Immunovaccine Inc. (CA)

Declarations19 total

▲

4 - Director of IssuerExecutives13 Feb 2018Immunovaccine Inc.

30,146 CAD18SEDI

16,000 shares@ CA$1.88419.0% of flowCommon SharesTSXSEDI:3132324

Canonical exit: 14 May 2018 (T+90)

▲

4 - Director of IssuerExecutives12 Jan 2018Immunovaccine Inc.

11,501 CAD17SEDI

5,300 shares@ CA$2.173.5% of flowCommon SharesTSXSEDI:3118002

Canonical exit: 12 Apr 2018 (T+90)

●

4 - Director of IssuerExecutives21 Jun 2017Immunovaccine Inc.

10,400 CAD16SEDI

8,000 shares@ CA$1.3029.6% of flowCommon SharesTSXSEDI:3024643

▲

4 - Director of IssuerExecutives20 Apr 2017Immunovaccine Inc.

24,000 CAD18SEDI

20,000 shares@ CA$1.2070.4% of flowCommon SharesTSXSEDI:2998598

Canonical exit: 19 Jul 2017 (T+90)

▲

4 - Director of IssuerExecutives9 Feb 2017Immunovaccine Inc.

21,974 CAD18SEDI

22,300 shares@ CA$0.98547.2% of flowCommon SharesTSXSEDI:2955689

Canonical exit: 10 May 2017 (T+90)

▲

4 - Director of IssuerExecutives7 Feb 2017Immunovaccine Inc.

5,335 CAD17SEDI

5,000 shares@ CA$1.0671.8% of flowCommon SharesTSXSEDI:2954858

Canonical exit: 8 May 2017 (T+90)

●

4 - Director of IssuerExecutives9 Dec 2016Immunovaccine Inc.

67,500 CAD19SEDI

90,000 shares@ CA$0.7522.2% of flowCommon SharesTSXSEDI:2925376

▲

4 - Director of IssuerExecutives16 Nov 2016Immunovaccine Inc.

6,000 CAD17SEDI

8,000 shares@ CA$0.751.9% of flowCommon SharesTSXSEDI:2914216

Canonical exit: 14 Feb 2017 (T+90)

▲

4 - Director of IssuerExecutives18 Nov 2016Immunovaccine Inc.

16,000 CAD18SEDI

20,000 shares@ CA$0.805.1% of flowCommon SharesTSXSEDI:2914511

Canonical exit: 16 Feb 2017 (T+90)

▲

4 - Director of IssuerExecutives14 Nov 2016Immunovaccine Inc.

1,350 CAD17SEDI

1,800 shares@ CA$0.750.4% of flowCommon SharesTSXSEDI:2912542

Canonical exit: 12 Feb 2017 (T+90)

▲

4 - Director of IssuerExecutives14 Nov 2016Immunovaccine Inc.

21,690 CAD18SEDI

30,000 shares@ CA$0.7236.8% of flowCommon SharesTSXSEDI:2912541

Canonical exit: 12 Feb 2017 (T+90)

▲

4 - Director of IssuerExecutives14 Nov 2016Immunovaccine Inc.

45,480 CAD18SEDI

60,000 shares@ CA$0.75814.3% of flowCommon SharesTSXSEDI:2912539

Canonical exit: 12 Feb 2017 (T+90)

●

4 - Director of IssuerExecutives27 Apr 2015Immunovaccine Inc.

0SEDI

Common SharesTSXSEDI:2912540

▲

4 - Director of IssuerExecutives25 Aug 2016Immunovaccine Inc.

6,900 CAD17SEDI

10,000 shares@ CA$0.692.2% of flowCommon SharesTSXSEDI:2882082

Canonical exit: 23 Nov 2016 (T+90)

▲

4 - Director of IssuerExecutives12 Jul 2016Immunovaccine Inc.

4,225 CAD15SEDI

6,500 shares@ CA$0.651.3% of flowCommon SharesTSXSEDI:2865199

Canonical exit: 10 Oct 2016 (T+90)

▲

4 - Director of IssuerExecutives12 Jul 2016Immunovaccine Inc.

1,005 CAD15SEDI

1,500 shares@ CA$0.670.3% of flowCommon SharesTSXSEDI:2865200

Canonical exit: 10 Oct 2016 (T+90)

●

4 - Director of IssuerExecutives8 Jun 2016Immunovaccine Inc.

27,500 CAD14SEDI

50,000 shares@ CA$0.558.8% of flowCommon SharesTSXSEDI:2849306

●

4 - Director of IssuerExecutives27 Apr 2015Immunovaccine Inc.

0SEDI

Common SharesTSXSEDI:2826757

▲

4 - Director of IssuerExecutives15 Apr 2016Immunovaccine Inc.

13,000 CAD11SEDI

20,000 shares@ CA$0.654.1% of flowCommon SharesTSXSEDI:2826758

Canonical exit: 14 Jul 2016 (T+90)

19 of 19 declarations